These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 4735415)

  • 21. Drug-induced changes in monoamine levels in the sympathetic adrenergic ganglion cells and terminals. A histochemical study.
    Norberg KA
    Acta Physiol Scand; 1965 Nov; 65(3):221-34. PubMed ID: 4379526
    [No Abstract]   [Full Text] [Related]  

  • 22. Possible role of brain serotonin and dopamine in controlling male sexual behavior.
    Gessa GL; Tagliamonte A
    Adv Biochem Psychopharmacol; 1974; 11(0):217-28. PubMed ID: 4276859
    [No Abstract]   [Full Text] [Related]  

  • 23. The action L-dopa on sexual behaviour of male rats.
    Da Prada M; Carruba M; Saner A; O'Brien A; Pletscher A
    Brain Res; 1973 Jun; 55(2):383-9. PubMed ID: 4541349
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects on shock-elicited aggression in mice of preferentially protecting brain monoamines against the depleting action of reserpine.
    Butcher LL; Dietrich AP
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 277(1):61-70. PubMed ID: 4350470
    [No Abstract]   [Full Text] [Related]  

  • 25. A study of the central effects of 5,6-dihydroxytryptamine.
    Longo VG; Scotti de Carolis A; Liuzzi A; Massotti M
    Adv Biochem Psychopharmacol; 1974; 10():109-20. PubMed ID: 4546514
    [No Abstract]   [Full Text] [Related]  

  • 26. Spectrum analysis of electroencephalographic changes induced by some psychoactive agents. Their possible relationship to changes in cerebral biogenic amine levels.
    Eidelberg E; Miller MK; Long M
    Int J Neuropharmacol; 1966 Jan; 5(1):59-74. PubMed ID: 4380483
    [No Abstract]   [Full Text] [Related]  

  • 27. Production of a stereotyped behaviour in rats by dopamine in the absence of noradrenaline.
    Scheel-Krüger J; Randrup A
    Acta Pharmacol Toxicol (Copenh); 1967; 25():Suppl 4:61. PubMed ID: 5630954
    [No Abstract]   [Full Text] [Related]  

  • 28. Dopa-induced locomotor stimulation after inhibition of extracerebral decarboxylase.
    Bartholini G; Blum JE; Pletscher A
    J Pharm Pharmacol; 1969 May; 21(5):297-301. PubMed ID: 4390121
    [No Abstract]   [Full Text] [Related]  

  • 29. Stereotype hyperactive behaviour produced by dopamine in the absence of noradrenaline.
    Scheel-Krüger J; Randrup A
    Life Sci; 1967 Jul; 6(13):1389-98. PubMed ID: 6035768
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of dopalanine on behaviour in mice depleted of norepinephrine or serotonin.
    Chruściel TL; Herman ZS
    Psychopharmacologia; 1969; 14(2):124-34. PubMed ID: 5350621
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies on the formation of 6-hydroxydopamine in mouse brain after administration of 2,4,5-trihydroxyphenylalanine (6-hydroxyDOPA).
    Evans JM; Cohen G
    J Neurochem; 1989 May; 52(5):1461-7. PubMed ID: 2496200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. (S)-norepinephrine in the tissues of mice and rats given racemic erythro-3,4-dihydroxyphenylserine (DOPS).
    Porter CC; Torchiana ML; Stone CA
    Life Sci I; 1972 Aug; 11(16):787-95. PubMed ID: 4540250
    [No Abstract]   [Full Text] [Related]  

  • 33. Disulfiram and the drug-induced effects on motility.
    Maj J; Przegaliński E; Wielosz M
    J Pharm Pharmacol; 1968 Mar; 20(3):247-8. PubMed ID: 4385060
    [No Abstract]   [Full Text] [Related]  

  • 34. Withdrawal from repeated administration of a low dose of reserpine induced opposing adaptive changes in the noradrenaline and serotonin system function: a behavioral and neurochemical ex vivo and in vivo studies in the rat.
    Antkiewicz-Michaluk L; Wąsik A; Możdżeń E; Romańska I; Michaluk J
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Mar; 57():146-54. PubMed ID: 25445479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of L-dopa on accumulation and efflux of monoamines in particles of rat brain homogenates.
    Ng LK; Colburn RW; Kopin IJ
    J Pharmacol Exp Ther; 1972 Nov; 183(2):316-25. PubMed ID: 5083548
    [No Abstract]   [Full Text] [Related]  

  • 36. Brain biogenic amines and pituitary-adrenocortical function in the rat.
    Maickel RP; Martel RR
    Pharmacol Biochem Behav; 1983 Aug; 19(2):321-5. PubMed ID: 6634881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of deserpidine and pargyline on the levels of biogenic amines in brain, liver and heart of mice.
    Everett GM; Borcherding J; Morse P
    Res Commun Chem Pathol Pharmacol; 1972 Mar; 3(2):245-8. PubMed ID: 4679851
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of reserpine, alpha-methyl-p-tyrosine, p-chlorophenylalanine and pargyline on levorphanol-induced running activity in mice.
    Hollinger M
    Arch Int Pharmacodyn Ther; 1969 Jun; 179(2):419-24. PubMed ID: 5367312
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro inhibition of noradrenaline-3H uptake by reserpine and tetrabenazine in mouse cerebral cortex tissues.
    Ross SB; Renyi AL
    Acta Pharmacol Toxicol (Copenh); 1966; 24(1):73-88. PubMed ID: 4381156
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of inhibition of monoamine oxidase on the levels of 5-S-cysteinyl adducts of catechols in dopaminergic regions of the brain of the guinea pig.
    Fornstedt B; Carlsson A
    Neuropharmacology; 1991 May; 30(5):463-8. PubMed ID: 1907723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.